Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Norton

Showing results (71-80 of 293) with videos related to

Pageof 30
Sort By:
The American Journal of Surgical Pathology|September 21, 2012
DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumorsYong H Wen, Edi Brogi, Zhaoshi Zeng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC ExperienceNikita Sareen, Abha Kulkarni, Diana Lake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancerCatherine Van Poznak, Lee Tan, Katherine S Panageas, et al.
Cell|January 13, 2010
Tumor self-seeding by circulating cancer cellsMi-Young Kim, Thordur Oskarsson, Swarnali Acharyya, et al.
Breast Cancer Research and Treatment|July 14, 2017
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancerGulisa Turashvili, Joanne F Chou, Edi Brogi, et al.
Scientific Reports|November 8, 2024
Normal tissue transcriptional signatures for tumor-type-agnostic phenotype predictionCorey Weistuch, Kevin A Murgas, Jiening Zhu, et al.
The American Journal of Surgical Pathology|October 15, 2005
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovaryCarmen Tornos, Robert Soslow, Shirley Chen, et al.
NPJ Breast Cancer|July 20, 2017
Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysisMerav Fraenkel, David B Geffen, Victor Novack, et al.
Breast Cancer Research and Treatment|June 30, 2005
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Kelly Brogan, Katherine S Panageas, et al.
Plos One|August 14, 2013
Association between bone mineral density and incidence of breast cancerMerav Fraenkel, Victor Novack, Yair Liel, et al.
Pageof 30

Showing results (71-80 of 293) with videos related to

Sort By:
Pageof 30
The American Journal of Surgical Pathology|September 21, 2012
DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumorsYong H Wen, Edi Brogi, Zhaoshi Zeng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC ExperienceNikita Sareen, Abha Kulkarni, Diana Lake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancerCatherine Van Poznak, Lee Tan, Katherine S Panageas, et al.
Cell|January 13, 2010
Tumor self-seeding by circulating cancer cellsMi-Young Kim, Thordur Oskarsson, Swarnali Acharyya, et al.
Breast Cancer Research and Treatment|July 14, 2017
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancerGulisa Turashvili, Joanne F Chou, Edi Brogi, et al.
Scientific Reports|November 8, 2024
Normal tissue transcriptional signatures for tumor-type-agnostic phenotype predictionCorey Weistuch, Kevin A Murgas, Jiening Zhu, et al.
The American Journal of Surgical Pathology|October 15, 2005
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovaryCarmen Tornos, Robert Soslow, Shirley Chen, et al.
NPJ Breast Cancer|July 20, 2017
Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysisMerav Fraenkel, David B Geffen, Victor Novack, et al.
Breast Cancer Research and Treatment|June 30, 2005
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Kelly Brogan, Katherine S Panageas, et al.
Plos One|August 14, 2013
Association between bone mineral density and incidence of breast cancerMerav Fraenkel, Victor Novack, Yair Liel, et al.
Pageof 30